Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2014 Nov 1;67(3):246–253. doi: 10.1097/QAI.0000000000000312

Figure 4.

Figure 4

Kaplan-Meier curve of time to virologic failure in participants grouped by whether or not M184V, K103N, Y181C, and/or G190A was detected in baseline (pre-ART) viral population, and if detected, the proportion of the mutant population: 0% (solid line), >0% to <2% (short dashed line), and ≥2% (long dash line).

Note: The number of participants at risk at each time point is listed and the number experiencing virologic failure is in parentheses.